Pharmaceuticals Licensing Agreements Analysis Report 2024 with a Directory of Deals Signed Since 2019 Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Licensing Deals in Pharmaceuticals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Pharmaceuticals...

InveniAI's AlphaMeld Platform Debuts the Addition of ChatAlphaMeld™, A Powerful Tool Designed to Scale Target and Drug Discovery and Development Powered by GPT-4, ChatAlphaMeld enables user interaction across functional stakeholders to automate hypothesis generation and prioritization Integrated into the AlphaMeld workflow, ChatAlphaMeld is...

InveniAI and Kyowa Kirin Announce Achievement of Milestone in Research Collaboration GUILFORD, Conn. and TOKYO, May 31, 2022 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug and target discovery...

Indiana Biosciences Research Institute Names Next Research Fellow, Director of New Single Cell Bioanalytics Core Laboratory INDIANAPOLIS, Oct. 31, 2016 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced Michael Pugia, Ph.D., as a Research Fellow and Director of the new Bioanalytics Core...